Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases

Journal of Controlled Release

Volumn 264, Issue , 2017, Pages 306-332

  Tapeinos, Christos ^a   Battaglini, Matteo ^a,b   Ciofani, Gianni ^a,c  

^a Center for Micro BioRobotics at SSSA   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c POLITECNICO DI TORINO   (Italy)

Author keywords

BBB; Glioblastoma multiforme; Neurodegenerative diseases; NLCs; SLNs

Indexed keywords

CONTROLLED DRUG DELIVERY; NANOPARTICLES; NANOSYSTEMS; TARGETED DRUG DELIVERY;

FABRICATION TECHNIQUE; GLIOBLASTOMA MULTIFORME; NANOSTRUCTURED LIPID CARRIERS; NLCS; SLNS; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES; THERAPEUTIC EFFICACY;

NEURODEGENERATIVE DISEASES;

CENTRAL NERVOUS SYSTEM AGENTS; DENDRIMER; INORGANIC NANOPARTICLE; LIPOPLEX; LIPOPROTEIN; LIPOSOME; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; POLYMER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; LIPID;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN DISEASE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; MATERIAL STATE; MICELLE (PHYSICAL); MULTIPLE SCLEROSIS; NANOCHEMISTRY; NANOFABRICATION; NONHUMAN; PARKINSON DISEASE; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SYNTHESIS; ANIMAL; CHEMISTRY; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; NANOPARTICLES;

EID: 85029626486     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2017.08.033     Document Type: Review

References (180)

1. Stöber, W., Fink, A., Bohn, E., Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 26 (1968), 62–69, 10.1016/0021-9797 (68)90272-5.
2. Wilhelm, S., Tavares, A.J., Dai, Q., Ohta, S., Audet, J., Dvorak, H.F., Chan, W.C.W., Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater., 1, 2016, 16014, 10.1038/natrevmats.2016.14.
3. Shi, J., Kantoff, P.W., Wooster, R., Farokhzad, O.C., Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17 (2016), 20–37, 10.1038/nrc.2016.108.
4. Jayagopal, A., Linton, M.F., Fazio, S., Haselton, F.R., Insights into atherosclerosis using nanotechnology. Curr Atheroscler Rep 12 (2010), 209–215, 10.1007/s11883-010-0106-7.
5. Lobatto, M.E., Fuster, V., Fayad, Z.A., Mulder, W.J.M., Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat. Rev. Drug Discov. 10 (2011), 835–852, 10.1038/nrd3578.
6. Sargent, J., Cardiovascular disease: new nanomedicines for treating atherosclerotic plaques. Nat. Rev. Endocrinol., 11, 2015, 256, 10.1038/nrendo.2015.35.
7. Yang, X., Jin, L., Yao, L., Shen, F.H., Shimer, A., Li, X., Antioxidative nanofullerol prevents intervertebral disk degeneration. Int. J. Nanomedicine, 2014, 2419, 10.2147/IJN.S60853.
8. Jin, L., Ding, M., Oklopcic, A., Aghdasi, B., Xiao, L., Li, Z., Jevtovic-Todorovic, V., Li, X., Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides. Nanomedicine 13 (2017), 2049–2059, 10.1016/j.nano.2017.03.015.
9. Dvir, T., Bauer, M., Schroeder, A., Tsui, J.H., Anderson, D.G., Langer, R., Liao, R., Kohane, D.S., Nanoparticles targeting the infarcted heart. Nano Lett. 11 (2011), 4411–4414, 10.1021/nl2025882.
10. Suarez, S., Almutairi, A., Christman, K.L., Micro- and nanoparticles for treating cardiovascular disease. Biomater. Sci. 3 (2015), 564–580, 10.1039/C4BM00441H.
11. Wohlfart, S., Gelperina, S., Kreuter, J., Transport of drugs across the blood–brain barrier by nanoparticles. J. Control. Release 161 (2012), 264–273, 10.1016/j.jconrel.2011.08.017.
12. Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., Bernardino, L., Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases. J. Control. Release 235 (2016), 34–47, 10.1016/j.jconrel.2016.05.044.
13. Kreuter, J., Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?. Adv. Drug Deliv. Rev. 71 (2014), 2–14, 10.1016/j.addr.2013.08.008.
14. Patel, T., Zhou, J., Piepmeier, J.M., Saltzman, W.M., Polymeric nanoparticles for drug delivery to the central nervous system. Adv. Drug Deliv. Rev. 64 (2012), 701–705, 10.1016/j.addr.2011.12.006.
15. Rajera, R., Nagpal, K., Singh, S.K., Mishra, D.N., Niosomes: a controlled and novel drug delivery system. Biol. Pharm. Bull. 34 (2011), 945–953, 10.1248/bpb.34.945.
16. Ag Seleci, D., Seleci, M., Walter, J.G., Stahl, F., Scheper, T., Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J. Nanomater., 2016, 2016, 10.1155/2016/7372306.
17. Chaurasia, S., Dogra, S.S., European journal of Ejpmr Transfersomes: novel approach for intranasal delivery. Eur. J. Pharm. Rev. Artic. Eur. J. Pharm. Med. Res. Med. Res. 4 (2017), 192–203.
18. Pattni, B.S., Chupin, V.V., Torchilin, V.P., New developments in liposomal drug delivery. Chem. Rev. 115 (2015), 10938–10966, 10.1021/acs.chemrev.5b00046.
19. Sawant, R.R., Torchilin, V.P., Challenges in development of targeted liposomal therapeutics. AAPS J. 14 (2012), 303–315, 10.1208/s12248-012-9330-0.
20. Ezzati Nazhad Dolatabadi, J., Omidi, Y., Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems. TrAC - Trends Anal. Chem. 77 (2016), 100–108, 10.1016/j.trac.2015.12.016.
21. Beloqui, A., Solinís, M.Á., Rodríguez-Gascón, A., Almeida, A.J., Préat, V., Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine 12 (2016), 143–161, 10.1016/j.nano.2015.09.004.
22. Agrawal, M., Ajazuddin, D.K. Tripathi, Saraf, S., Saraf, S., Antimisiaris, S.G., Mourtas, S., Hammarlund-Udenaes, M., Alexander, A., Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease. J. Control. Release 260 (2017), 61–77, 10.1016/j.jconrel.2017.05.019.
23. Gamarra, L.F., Getting into the brain: liposome-based strategies for effective drug delivery across the blood – brain barrier. Int. J. Nanomedicine, 2016, 5381–5414.
24. Varshosaz, J., Taymouri, S., Pardakhty, A., Asadi-Shekaari, M., Babaee, A., Niosomes of ascorbic acid and α-tocopherol in the cerebral ischemia-reperfusion model in male rats. Biomed. Res. Int., 2014, 2014, 10.1155/2014/816103.
25. Haque, S., Md, S., Alam, M.I., Sahni, J.K., Ali, J., Baboota, S., Nanostructure-based drug delivery systems for brain targeting. Drug Dev. Ind. Pharm. 38 (2012), 387–411, 10.3109/03639045.2011.608191.
26. Spuch, C., Navarro, C., Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer's disease and Parkinson's disease). J. Drug Deliv. 2011 (2011), 1–12, 10.1155/2011/469679.
27. Gasco, M.R., Method for Producing Solid Lipid Microspheres Having a Narrow Size Distribution, US005250236A. 1993.
28. Gasco, M.R., Lipid nanoparticles: perspectives and challenges. Adv. Drug Deliv. Rev. 59 (2007), 377–378, 10.1016/j.addr.2007.05.004.
29. Müller, S., Mäder, R.H., Gohla, K., Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000), 161–177.
30. Naseri, N., Valizadeh, H., Zakeri-Milani, P., Solid lipid nanoparticles and nanostructured lipid carriers: structure preparation and application. Adv. Pharm. Bull. 5 (2015), 305–313, 10.15171/apb.2015.043.
31. Feng, L., Mumper, R.J., A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett. 334 (2013), 157–175, 10.1016/j.canlet.2012.07.006.
32. Muller, S.A.W.R.H., Radtke, M., Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242 (2002), 121–128.
33. Das, S., Ng, W.K., Tan, R.B.H., Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. Eur. J. Pharm. Sci. 47 (2012), 139–151, 10.1016/j.ejps.2012.05.010.
34. Li, F., Wang, Y., Liu, Z., Lin, X., He, H., Tang, X., Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers. Drug Dev. Ind. Pharm. 36 (2010), 508–517, 10.3109/03639040903264397.
35. Alam, T., Pandit, J., Vohora, D., Aqil, M., Ali, A., Sultana, Y., Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin. Drug Deliv. 12 (2015), 181–194, 10.1517/17425247.2014.945416.
36. Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H.P., Plank, H., Zimmer, A., Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int. J. Pharm. 419 (2011), 329–338, 10.1016/j.ijpharm.2011.07.040.
37. Mehnert, W., Mäder, K., Solid lipid nanoparticles. Adv. Drug Deliv. Rev. 64 (2012), 83–101, 10.1016/j.addr.2012.09.021.
38. Parhi, R., Suresh, P., Production of solid lipid nanoparticles-drug loading and release mechanism. J. Chem. Pharm. Res. 2 (2010), 211–227.
39. Karami, M.A., Sharif Makhmal Zadeh, B., Kouchak, M., Moghimipour, E., Superoxide dismutase-loaded solid lipid nanoparticles prepared by cold homogenization method: characterization and permeation study through burned rat skin. Jundishapur J. Nat. Pharm. Prod., 11, 2016, 10.17795/jjnpp-33968.
40. Fornaguera, C., Dols-Perez, A., Calderó, G., García-Celma, M.J., Camarasa, J., Solans, C., PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. J. Control. Release 211 (2015), 134–143, 10.1016/j.jconrel.2015.06.002.
41. Gelperina, S., Maksimenko, O., Khalansky, A., Vanchugova, L., Shipulo, E., Abbasova, K., Berdiev, R., Wohlfart, S., Chepurnova, N., Kreuter, J., Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Eur. J. Pharm. Biopharm. 74 (2010), 157–163, 10.1016/j.ejpb.2009.09.003.
42. Tapeinos, C., Larrañaga, A., Sarasua, J.-R., Pandit, A., Larranaga, A., Sarasua, J.-R., Pandit, A., Functionalised collagen spheres reduce H2O2 mediated apoptosis by scavenging overexpressed ROS. Nanomedicine, 2017, 10.1016/j.nano.2017.03.022.
43. Venishetty, V.K., Komuravelli, R., Kuncha, M., Sistla, R., Diwan, P.V., Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine 9 (2013), 111–121, 10.1016/j.nano.2012.03.003.
44. Wang, M., Qin, L., Li, K., Zhu, R., Wang, W., Wang, S., The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles. AAPS PharmSciTech 13 (2012), 1348–1354, 10.1208/s12249-012-9862-8.
45. Pooja, D., Tunki, L., Kulhari, H., Reddy, B.B., Sistla, R., Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method. Data Br. 6 (2016), 15–19, 10.1016/j.dib.2015.11.038.
46. Xia, D., Shrestha, N., Van De Streek, J., Mu, H., Yang, M., Spray drying of fenofibrate loaded nanostructured lipid carriers. Asian J. Pharm. Sci. 11 (2016), 507–515, 10.1016/j.ajps.2016.01.001.
47. M., R., Freitas, C., Spray-drying of solid lipid nanoparticles (SLNTM). Eur. J. Pharm. Biopharm. 46 (1998), 145–151.
48. Weber, S., Zimmer, A., Pardeike, J., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application : a review of the state of the art. Eur. J. Pharm. Biopharm., 2013, 10.1016/j.ejpb.2013.08.013.
49. Campardelli, R., Cherain, M., Perfetti, C., Iorio, C., Scognamiglio, M., Reverchon, E., Della, G., Lipid nanoparticles production by supercritical fluid assisted emulsion – diffusion. J. Supercrit. Fluids 82 (2013), 34–40, 10.1016/j.supflu.2013.05.020.
50. Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Serpe, L., Trotta, M., Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J. Microencapsul. 28 (2011), 537–548, 10.3109/02652048.2011.590615.
51. Tapeinos, C., Efthimiadou, E.K., Boukos, N., Kordas, G., Sustained release profile of quatro stimuli nanocontainers as a multi sensitive vehicle exploiting cancer characteristics. Colloids Surf. B: Biointerfaces 148 (2016), 95–103, 10.1016/j.colsurfb.2016.08.019.
52. Efthimiadou, E.K., Tapeinos, C., Chatzipavlidis, A., Boukos, N., Fragogeorgi, E., Palamaris, L., Loudos, G., Kordas, G., Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study. Int. J. Pharm., 461, 2014, 10.1016/j.ijpharm.2013.11.037.
53. Tapeinos, C., Kartsonakis, I., Liatsi, P., Daniilidis, I., Kordas, G., Synthesis and characterization of magnetic nanocontainers. J. Am. Ceram. Soc., 91, 2008, 10.1111/j.1551-2916.2007.02240.x.
54. Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (2013), 991–1003, 10.1038/nmat3776.
55. Cao, H., Dong, Y., Bre, L., Tapeinos, C., Wang, W., Pandit, A., An acetal-based polymeric crosslinker with controlled pH-sensitivity. RSC Adv. 6 (2016), 9604–9611, 10.1039/C6RA00423G.
56. Efthimiadou, E.K., Tapeinos, C., Bilalis, P., Kordas, G., New approach in synthesis, characterization and release study of pH-sensitive polymeric micelles, based on PLA-Lys-b-PEGm, conjugated with doxorubicin. J. Nanopart. Res., 13, 2011, 10.1007/s11051-011-0579-5.
57. Tapeinos, C., Pandit, A., Physical, chemical, and biological structures based on ROS-sensitive moieties that are able to respond to oxidative microenvironments. Adv. Mater. 28 (2016), 5553–5585, 10.1002/adma.201505376.
58. Efthimiadou, E.K., Tapeinos, C., Tziveleka, L.A., Boukos, N., Kordas, G., PH- and thermo-responsive microcontainers as potential drug delivery systems: morphological characteristic, release and cytotoxicity studies. Mater. Sci. Eng. C 37 (2014), 271–277, 10.1016/j.msec.2014.01.024.
59. Tapeinos, C., Efthimiadou, E.K., Boukos, N., Charitidis, C.a., Koklioti, M., Kordas, G., Microspheres as therapeutic delivery agents: synthesis and biological evaluation of pH responsiveness. J. Mater. Chem. B, 2013, 194–203, 10.1039/c2tb00013j.
60. Bizeau, J., Tapeinos, C., Marella, C., Larrañaga, A., Pandit, A., Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers. Colloids Surf. B: Biointerfaces 159 (2017), 30–38, 10.1016/j.colsurfb.2017.07.081.
61. Masserini, M., Nanoparticles for brain drug delivery. ISRN Biochem. 2013 (2013), 1–18, 10.1155/2013/238428.
62. Craparo, E.F., Bondì, M.L., Pitarresi, G., Gennara, Cavallaro, Nanoparticulate Systems for Drug Delivery and Targeting to the central nervous system. CNS Neurosci. Ther. 17 (2011), 670–677, 10.1111/j.1755-5949.2010.00199.x.
63. Yang, H., Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm. Res. 27 (2010), 1759–1771, 10.1007/s11095-010-0141-7.
64. Morshed, R.A., Cheng, Y., Auffinger, B., Wegscheid, M.L., Lesniak, M.S., The potential of polymeric micelles in the context of glioblastoma therapy. Front. Pharmacol., 4, 2013, 10.3389/fphar.2013.00157.
65. Thakur, V.K., Thakur, M.K., (eds.) Handbook of Polymers for Pharmaceutical Technologies, 2015, John Wiley & Sons, Inc., Hoboken, NJ, USA, 10.1002/9781119041450.
66. Esteves, M., Cristóvão, A.C., Saraiva, T., Rocha, S.M., Baltazar, G., Ferreira, L., Bernardino, L., Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease. Front. Aging Neurosci. 7 (2015), 1–10, 10.3389/fnagi.2015.00020.
67. Lee, C.Y., Ooi, I.H., Preparation of temozolomide-loaded nanoparticles for glioblastoma multiforme targeting-ideal versus reality. Pharmaceuticals, 9, 2016, 10.3390/ph9030054.
68. Führmann, T., Ghosh, M., Otero, A., Goss, B., Dargaville, T.R., Pearse, D.D., Dalton, P.D., Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis. Neurosci. Lett. 602 (2015), 126–132, 10.1016/j.neulet.2015.06.049.
69. Fonseca-santos, B., Daflon Palmira Gremiao, M., Chorilli, M., Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease. Int. J. Nanomedicine 10 (2015), 4981–5003, 10.2147/IJN.S87148.
70. Hadavi, D., Poot, A.A., Biomaterials for the treatment of Alzheimer's disease. Front. Bioeng. Bioteechnol., 4, 2016, 10.3389/fbioe.2016.00049.
71. Somani, S., Dufès, C., Applications of dendrimers for brain delivery and cancer therapy. Nanomedicine 9 (2014), 2403–2414, 10.2217/nnm.14.130.
72. Pandita, D., Poonia, N., Kumar, S., Lather, V., Madaan, K., Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J. Pharm. Bioallied Sci., 6, 2014, 139, 10.4103/0975-7406.130965.
73. Xu, L., Zhang, H., Wu, Y., Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem. Neurosci. 5 (2014), 2–13, 10.1021/cn400182z.
74. Zhao, J., Zhang, B., Shen, S., Chen, J., Zhang, Q., Jiang, X., Pang, Z., CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery. J. Colloid Interface Sci. 450 (2015), 396–403, 10.1016/j.jcis.2015.03.019.
75. Beg, S., Samad, A., Alam, M.I., Nazish, I., Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS Neurol. Disord. Drug Targets 10 (2011), 576–588 http://www.ncbi.nlm.nih.gov/pubmed/21631401.
76. Glaser, T., Han, I., Wu, L., Zeng, X., Targeted nanotechnology in glioblastoma multiforme. Front. Pharmacol. 8 (2017), 1–14, 10.3389/fphar.2017.00166.
77. Cherukula, K., Manickavasagam Lekshmi, K., Uthaman, S., Cho, K., Cho, C.-S., Park, I.-K., Multifunctional inorganic nanoparticles: recent progress in thermal therapy and imaging. Nano, 6, 2016, 76, 10.3390/nano6040076.
78. Anselmo, A.C., Mitragotri, S., A review of clinical translation of inorganic nanoparticles. AAPS J. 17 (2015), 1041–1054, 10.1208/s12248-015-9780-2.
79. Mahmoudi, K., Hadjipanayis, C.G., The application of magnetic nanoparticles for the treatment of brain tumors. Front. Chem. 2 (2014), 1–5, 10.3389/fchem.2014.00109.
80. Busquets, M., Sabaté, R., Estelrich, J., Potential applications of magnetic particles to detect and treat Alzheimer's disease. Nanoscale Res. Lett., 9, 2014, 538, 10.1186/1556-276X-9-538.
81. Joh, D.Y., Sun, L., Stangl, M., Al Zaki, A., Murty, S., Santoiemma, P.P., Davis, J.J., Baumann, B.C., Alonso-Basanta, M., Bhang, D., Kao, G.D., Tsourkas, A., Dorsey, J.F., Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One, 8, 2013, 10.1371/journal.pone.0062425.
82. Gao, N., Sun, H., Dong, K., Ren, J., Qu, X., Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease. Chem. - A Eur. J. 21 (2015), 829–835, 10.1002/chem.201404562.
83. Kim, C.K., Kim, T., Choi, I.Y., Soh, M., Kim, D., Kim, Y.J., Jang, H., Yang, H.S., Kim, J.Y., Park, H.K., Park, S.P., Park, S., Yu, T., Yoon, B.W., Lee, S.H., Hyeon, T., Ceria nanoparticles that can protect against ischemic stroke. Angew. Chem. Int. Ed. 51 (2012), 11039–11043, 10.1002/anie.201203780.
84. Zhang, X.-X., McIntosh, T.J., Grinstaff, M.W., Functional lipids and lipoplexes for improved gene delivery. Biochimie 94 (2012), 42–58, 10.1016/j.biochi.2011.05.005.
85. Schroeder, A., Levins, C.G., Cortez, C., Langer, R., Anderson, D.G., Lipid-based nanotherapeutics for siRNA delivery. J. Intern. Med. 267 (2010), 9–21, 10.1111/j.1365-2796.2009.02189.x.
86. Chen, W., Li, H., Liu, Z., Yuan, W., Lipopolyplex for therapeutic gene delivery and its application for the treatment of Parkinson's disease. Front. Aging Neurosci. 8 (2016), 1–10, 10.3389/fnagi.2016.00068.
87. Costa, P.M., Cardoso, A.L., Nóbrega, C., Pereira de almeida, L.F., Bruce, J.N., Canoll, P., Pedroso de Lima, M.C., MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Hum. Mol. Genet. 22 (2013), 904–918, 10.1093/hmg/dds496.
88. Zhou, J., Atsina, K.-B., Himes, B.T., Strohbehn, G.W., Saltzman, W.M., Novel delivery strategies for glioblastoma. Cancer J. 18 (2012), 89–99, 10.1097/PPO.0b013e318244d8ae.
89. Tros de Ilarduya, C., Sun, Y., Düzgüneş, N., Gene delivery by lipoplexes and polyplexes. Eur. J. Pharm. Sci. 40 (2010), 159–170, 10.1016/j.ejps.2010.03.019.
90. Nayerossadat, N., Ali, P., Maedeh, T., Viral and nonviral delivery systems for gene delivery. Adv. Biomed. Res., 1, 2012, 27, 10.4103/2277-9175.98152.
91. Huang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., Jiang, D., Zheng, G., Chen, H., Gao, X., GM1-modified lipoprotein-like nanoparticle: multifunctional Nanoplatform for the combination therapy of Alzheimer's disease. ACS Nano 9 (2015), 10801–10816, 10.1021/acsnano.5b03124.
92. Varkey, J., Mizuno, N., Hegde, B.G., Cheng, N., Steven, A.C., Langen, R., Α-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles. J. Biol. Chem. 288 (2013), 17620–17630, 10.1074/jbc.M113.476697.
93. K.M. McMahon, L. Foit, N.L. Angeloni, F.J. Giles, L.I. Gordon, C.S. Thaxton, Synthetic high-density lipoprotein-like nanoparticles as cancer therapy, in: 2015: pp. 129–150. doi: http://dx.doi.org/10.1007/978-3-319-16555-4_6.
94. Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., Rong, Z., Qi, H., Zheng, G., Chen, H., Gao, X., Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta. ACS Nano 8 (2014), 2345–2359, 10.1021/nn4058215.
95. Huang, H., Cruz, W., Chen, J., Zheng, G., Learning from biology: synthetic lipoproteins for drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7 (2015), 298–314, 10.1002/wnan.1308.
96. Cardoso, F.L., Brites, D., Brito, M.A., Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res. Rev. 64 (2010), 328–363, 10.1016/j.brainresrev.2010.05.003.
97. Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., Delattre, J.Y., Primary brain tumours in adults. Lancet 379 (2012), 1984–1996, 10.1016/S0140-6736(11)61346-9.
98. Koo, Y., Reddy, G., Bhojani, M., Schneider, R., Philbert, M., Rehemtulla, A., Ross, B., Kopelman, R., Brain cancer diagnosis and therapy with nanoplatforms☆. Adv. Drug Deliv. Rev. 58 (2006), 1556–1577, 10.1016/j.addr.2006.09.012.
99. LB, G., Bertels, C., JN, D., Interrater reliability of the nih stroke scale. Arch. Neurol. 46 (1989), 660–662.
100. Hinkle, J.L., Guanci, M.M., Acute ischemic stroke review. J. Neurosci. Nurs. 39 (2007), 285–293, 10.1097/01376517-200710000-00005 310.
101. Connolly Barbara, S., Lang Anthony, E., Pharmacological treatment of Parkinson disease. JAMA 311 (2014), 442–449, 10.1111/bcp.12170.
102. Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P.R., Rimmer, E., Scazufca, Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005), 2112–2117, 10.1016/S0140-6736(05)67889-0.Global.
103. Dolati, S., Babaloo, Z., Jadidi-Niaragh, F., Ayromlou, H., Sadreddini, S., Yousefi, M., Multiple sclerosis: therapeutic applications of advancing drug delivery systems. Biomed Pharmacother 86 (2017), 343–353, 10.1016/j.biopha.2016.12.010.
104. Kuo, Y.-C., Liang, C.-T., Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 32 (2011), 3340–3350, 10.1016/j.biomaterials.2011.01.048.
105. Kuo, Y.C., Te Liang, C., Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells. Colloids Surf. B: Biointerfaces 85 (2011), 131–137, 10.1016/j.colsurfb.2011.02.011.
106. Kuo, Y.C., Lee, I.H., Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy, J. Taiwan Inst. Chem. Eng. 61 (2015), 32–45, 10.1016/j.jtice.2015.12.012.
107. Kuo, Y.C., Lee, C.H., Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid. J. Pharm. Sci. 104 (2015), 1804–1814, 10.1002/jps.24388.
108. Kuo, Y.C., Wang, C.C., Carmustine-loaded catanionic solid lipid nanoparticles with serotonergic 1B receptor subtype antagonist for in vitro targeted delivery to inhibit brain cancer growth. J. Taiwan Inst. Chem. Eng. 46 (2015), 1–14, 10.1016/j.jtice.2014.08.035.
109. Kuo, Y.C., Lee, C.H., Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy. Life Sci. 146 (2016), 222–231, 10.1016/j.lfs.2016.01.025.
110. Kuo, Y.C., Chao, I.W., Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy. Biotechnol. Prog. 32 (2016), 480–490, 10.1002/btpr.2214.
111. Kuo, Y.C., Cheng, S.J., Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation. Int. J. Pharm. 499 (2016), 10–19, 10.1016/j.ijpharm.2015.12.054.
112. Y.-C. Kuo, I.-H. Wang, Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles., 2016. doi: http://dx.doi.org/10.3109/1061186X.2015.1132223.
113. Qu, J., Zhang, L., Chen, Z., Mao, G., Gao, Z., Lai, X., Zhu, X., Zhu, J., Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?. Drug Deliv. 23 (2016), 3408–3416, 10.1080/10717544.2016.1189465.
114. Estella-Hermoso De Mendoza, A., Préat, V., Mollinedo, F., Blanco-Prieto, M.J., In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma. J. Control. Release 156 (2011), 421–426, 10.1016/j.jconrel.2011.07.030.
115. Sharma, P., Dube, B., Sawant, K., Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia. J. Nanosci. Nanotechnol. 11 (2011), 6676–6682, 10.1166/jnn.2011.4235.
116. Jin, J., Bae, K.H., Yang, H., Lee, S.J., Kim, H., Kim, Y., Joo, K.M., Seo, S.W., Park, T.G., Nam, D.-H., In vivo specific delivery of c-met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjug. Chem. 22 (2011), 2568–2572, 10.1021/bc200406n.
117. Martins, S., Costa-Lima, S., Carneiro, T., Cordeiro-Da-Silva, A., Souto, E.B., Ferreira, D.C., Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int. J. Pharm. 430 (2012), 216–227, 10.1016/j.ijpharm.2012.03.032.
118. Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E., Ferreira, D., Brandl, M., Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int. J. Pharm. 439 (2012), 49–62, 10.1016/j.ijpharm.2012.09.054.
119. Martins, S.M., Sarmento, B., Nunes, C., Lúcio, M., Reis, S., Ferreira, D.C., Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur. J. Pharm. Biopharm. 85 (2013), 488–502, 10.1016/j.ejpb.2013.08.011.
120. Khajavinia, A., Varshosaz, J., Dehkordi, A.J., Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin. Nanotechnology, 23, 2012, 405101, 10.1088/0957-4484/23/40/405101.
121. Griveau, A., Bejaud, J., Anthiya, S., Avril, S., Autret, D., Garcion, E., Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death. Int. J. Pharm. 454 (2013), 765–774, 10.1016/j.ijpharm.2013.05.049.
122. Zanotto-Filho, A., Coradini, K., Braganhol, E., Schröder, R., de Oliveira, C.M., Simões-Pires, A., Battastini, A.M.O., Pohlmann, A.R., Guterres, C.M., Forcelini, Sílvia Stanisisçuaski Guterres, Beck, R.C.R., Moreira, J.C.F., Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur. J. Pharm. Biopharm. 83 (2013), 156–167, 10.1016/j.ejpb.2012.10.019.
123. Bernardi, A., Frozza, R.L., Hoppe, J.B., Salbego, C., Pohlmann, A.R., Battastini, A.M.O., Guterres, S.S., The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways. Int. J. Nanomedicine 8 (2013), 711–728, 10.2147/IJN.S40284.
124. Jose, S., Anju, S.S., Cinu, T.A., Aleykutty, N.A., Thomas, S., Souto, E.B., In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int. J. Pharm. 474 (2014), 6–13, 10.1016/j.ijpharm.2014.08.003.
125. Battaglia, L., Gallarate, M., Peira, E., Chirio, D., Muntoni, E., Biasibetti, E., Capucchio, M.T., Valazza, A., Panciani, P.P., Lanotte, M., Schiffer, D., Annovazzi, L., Caldera, V., Mellai, M., Riganti, C., Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: Preliminary in vitro studies. J. Pharm. Sci. 103 (2014), 2157–2165, 10.1002/jps.24002.
126. Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Muntoni, E., Riganti, C., Biasibetti, E., Capucchio, M.T., Valazza, A., Panciani, P., Lanotte, M., Annovazzi, L., Caldera, V., Mellai, M., Filice, G., Corona, S., Schiffer, D., Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. Eur. J. Pharm. Biopharm. 88 (2014), 746–758, 10.1016/j.ejpb.2014.10.017.
127. Madane, R.G., Mahajan, H.S., Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. Drug Deliv. 7544 (2014), 1–9, 10.3109/10717544.2014.975382.
128. Cohen, Z.R., Ramishetti, S., Peshes-Yaloz, N., Goldsmith, M., Wohl, A., Zibly, Z., Peer, D., Localized RNAi therapeutics of Chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. ACS Nano 9 (2015), 1581–1591, 10.1021/nn506248s.
129. Battaglia, L., Gallarate, M., Peira, E., Chirio, D., Solazzi, I., Giordano, S.M.A., Gigliotti, C.L., Riganti, C., Dianzani, C., Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies. Nanotechnology, 26, 2015, 255102, 10.1088/0957-4484/26/25/255102.
130. Chen, Z., Lai, X., Song, S., Zhu, X., Zhu, J., Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy. Drug Deliv. 23 (2015), 1369–1373, 10.3109/10717544.2015.1038857.
131. Song, S., Mao, G., Du, J., Zhu, X., Novel, R.G.D., Containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Drug Deliv. 0 (2015), 1–5, 10.3109/10717544.2015.1064186.
132. Wu, M., Fan, Y., Lv, S., Xiao, B., Ye, M., Zhu, X., Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Drug Deliv. 23 (2016), 2720–2725, 10.3109/10717544.2015.1058434.
133. Chen, Y.H., Pan, L.Z., Jiang, M., Li, D., Jin, L.J., Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Drug Deliv. 23 (2016), 1383–1392, 10.3109/10717544.2015.1049719.
134. Emami, J., Rezazadeh, M., Sadeghi, H., Khadivar, K., Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box–Behnken design. Pharm. Dev. Technol. 22 (2017), 370–382, 10.1080/10837450.2016.1189933.
135. Yu, D., Khan, O.F., Suvà, M.L., Dong, B., Panek, W.K., Xiao, T., Wu, M., Han, Y., Ahmed, A.U., Balyasnikova, I.V., Zhang, H.F., Sun, C., Langer, R., Anderson, D.G., Lesniak, M.S., Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proc. Natl. Acad. Sci., 201701911, 2017, 10.1073/pnas.1701911114.
136. Dahlman, J.E., Barnes, C., Khan, O.F., Thiriot, A., Jhunjunwala, S., Shaw, T.E., Xing, Y., Sager, H.B., Sahay, G., Speciner, L., Bader, A., Bogorad, R.L., Yin, H., Racie, T., Dong, Y., Jiang, S., Seedorf, D., Dave, A., Singh Sandhu, K., Webber, M.J., Novobrantseva, T., Ruda, V.M., Lytton-Jean, A.K.R., Levins, C.G., Kalish, B., Mudge, D.K., Perez, M., Abezgauz, L., Dutta, P., Smith, L., Charisse, K., Kieran, M.W., Fitzgerald, K., Nahrendorf, M., Danino, D., Tuder, R.M., Andrian, U.H. von, Akinc, A., Panigrahy, D., Schroeder, A., Koteliansky, V., Langer, R., Anderson, D.G., In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat. Nanotechnol. 9 (2014), 648–655, 10.1038/nnano.2014.84.
137. Zhuang, C.Y., Li, N., Wang, M., Zhang, X.N., Pan, W.S., Peng, J.J., Pan, Y.S., Tang, X., Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int. J. Pharm. 394 (2010), 179–185, 10.1016/j.ijpharm.2010.05.005.
138. Morsi, N.M., Ghorab, D.M., Badie, H.A., Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization. Pharm. Dev. Technol. 18 (2013), 736–744, 10.3109/10837450.2012.734513.
139. Lin, C., Chen, F., Ye, T., Zhang, L., Zhang, W., Liu, D., Xiong, W., Yang, X., Pan, W., A novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug: Vinpocetine. Int. J. Pharm. 465 (2014), 90–96, 10.1016/j.ijpharm.2014.02.013.
140. Kakkar, V., Muppu, S.K., Chopra, K., Kaur, I.P., Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur. J. Pharm. Biopharm. 85 (2013), 339–345, 10.1016/j.ejpb.2013.02.005.
141. mei Lu, Y., yun Huang, J., Wang, H., fang Lou, X., hua Liao, M., juan Hong, L., rong Tao, R., Ahmed, M.M., lei Shan, C., liang Wang, X., Fukunaga, K., zhong Du, Y., Han, F., Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials 35 (2014), 530–537, 10.1016/j.biomaterials.2013.09.093.
142. Tsai, M.J., Wu, P.C., Bin Huang, Y., Chang, J.S., Lin, C.L., Tsai, Y.H., Fang, J.Y., Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int. J. Pharm. 423 (2012), 461–470, 10.1016/j.ijpharm.2011.12.009.
143. Liu, Z., Zhang, L., He, Q., Liu, X., Chukwunweike Ikechukwu, O., Tong, L., Guo, L., Yang, H., Zhang, Q., Zhao, H., Gu, X., Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats. Int. J. Pharm. 489 (2015), 131–138, 10.1016/j.ijpharm.2015.04.049.
144. Liu, Z., Zhao, H., Shu, L., Zhang, Y., Okeke, C., Zhang, L., Li, J., Li, N., Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB. Drug Dev. Ind. Pharm. 41 (2015), 353–361, 10.3109/03639045.2013.861478.
145. Hsu, S.-H., Wen, C.-J., Al-Suwayeh, S.A., Chang, H.-W., Yen, T.-C., Fang, J.-Y., Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Nanotechnology, 21, 2010, 405101, 10.1088/0957-4484/21/40/405101.
146. Tsai, M.-J., Huang, Y.-B., Wu, P.-C., Fu, Y.-S., Kao, Y.-R., Fang, J.-Y., Tsai, Y.-H., Oral Apomorphine delivery from solid lipid nanoparticles with different Monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J. Pharm. Sci. 100 (2010), 547–557, 10.1002/jps.22285.
147. Liu, K.-S., Wen, C.-J., Yen, T.-C., Sung, K.C., Ku, M.-C., Wang, J.-J., Fang, J.-Y., Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers for efficient brain targeting. Nanotechnology, 23, 2012, 95103, 10.1088/0957-4484/23/9/095103.
148. Pardeshi, C.V., Belgamwar, V.S., Tekade, A.R., Surana, S.J., Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. J. Mater. Sci. Mater. Med. 24 (2013), 2101–2115, 10.1007/s10856-013-4965-7.
149. Gabal, Y.M., Kamel, A.O., Sammour, O.A., Elshafeey, A.H., Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int. J. Pharm. 473 (2014), 442–457, 10.1016/j.ijpharm.2014.07.025.
150. Zhao, Y.Z., Li, X., Lu, C.T., Lin, M., Chen, L.J., Xiang, Q., Zhang, M., Jin, R.R., Jiang, X., Shen, X.T., Li, X.K., Cai, J., Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats. Nanomedicine 10 (2014), 755–764, 10.1016/j.nano.2013.10.009.
151. Yang, C.-R., Zhao, X.-L., Hu, H.-Y., Li, K.-X., Sun, X., Li, L., Chen, D.-W., Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Chem. Pharm. Bull. (Tokyo). 58 (2010), 656–661, 10.1248/cpb.58.656.
152. Patel, P.A., Patil, S.C., Kalaria, D.R., Kalia, Y.N., Patravale, V.B., Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. Int. J. Pharm. 446 (2013), 16–23, 10.1016/j.ijpharm.2013.02.014.
153. Dhawan, S., Kapil, R., Singh, B., Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J. Pharm. Pharmacol. 63 (2011), 342–351, 10.1111/j.2042-7158.2010.01225.x.
154. Gobbi, M., Re, F., Canovi, M., Beeg, M., Gregori, M., Sesana, S., Sonnino, S., Brogioli, D., Musicanti, C., Gasco, P., Salmona, M., Masserini, M.E., Lipid-based nanoparticles with high binding affinity for amyloid-β1-42 peptide. Biomaterials 31 (2010), 6519–6529, 10.1016/j.biomaterials.2010.04.044.
155. Yusuf, M., Khan, M., Khan, R.A., Ahmed, B., Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model. J. Drug Target. 21 (2013), 300–311, 10.3109/1061186X.2012.747529.
156. Meng, F., Asghar, S., Gao, S., Su, Z., Song, J., Huo, M., Meng, W., Ping, Q., Xiao, Y., A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. Colloids Surf. B: Biointerfaces 134 (2015), 88–97, 10.1016/j.colsurfb.2015.06.025.
157. Laserra, S., Basit, A., Sozio, P., Marinelli, L., Fornasari, E., Cacciatore, I., Ciulla, M., Türkez, H., Geyikoglu, F., Di Stefano, A., Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization. Int. J. Pharm. 485 (2015), 183–191, 10.1016/j.ijpharm.2015.03.001.
158. Sachdeva, A.K., Misra, S., Pal Kaur, I., Chopra, K., Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence. Eur. J. Pharmacol. 747 (2015), 132–140, 10.1016/j.ejphar.2014.11.014.
159. Vedagiri, A., Thangarajan, S., Mitigating effect of chrysin loaded solid lipid nanoparticles against amyloid β25–35 induced oxidative stress in rat hippocampal region: an efficient formulation approach for Alzheimer's disease. Neuropeptides 58 (2016), 111–125, 10.1016/j.npep.2016.03.002.
160. Bondì, M.L., Craparo, E.F., Giammona, G., Drago, F., Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (London) 5 (2010), 25–32, 10.2217/nnm.09.67.
161. Gandomi, N., Varshochian, R., Atyabi, F., Ghahremani, M.H., Sharifzadeh, M., Amini, M., Dinarvand, R., Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines. Pharm. Dev. Technol., 22, 2017, 10.1080/10837450.2016.1226901.
162. Tiwari, R., Pathak, K., Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm. 415 (2011), 232–243, 10.1016/j.ijpharm.2011.05.044.
163. Eskandari, S., Varshosaz, J., Minaiyan, M., Tabbakhian, M., Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int. J. Nanomedicine 6 (2011), 363–371, 10.2147/IJN.S15881.
164. Guo, C.Y., Yang, C.F., Li, Q.L., Tan, Q., Xi, Y.W., Liu, W.N., Zhai, G.X., Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 430 (2012), 292–298, 10.1016/j.ijpharm.2012.03.042.
165. Bose, S., Du, Y., Takhistov, P., Michniak-Kohn, B., Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int. J. Pharm. 441 (2013), 56–66, 10.1016/j.ijpharm.2012.12.013.
166. Liu, L.L., Tang, Y., Gao, C., Li, Y., Chen, S., Xiong, T., Li, J., Du, M., Gong, Z., Chen, H., Liu, L.L., Yao, P., Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf. B: Biointerfaces 115 (2014), 125–131, 10.1016/j.colsurfb.2013.11.029.
167. Fang, M., Jin, Y., Bao, W., Gao, H., Xu, M., Wang, D., Wang, X., Yao, P., Liu, L., In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration. Int. J. Nanomedicine 7 (2012), 5395–5404, 10.2147/IJN.S36257.
168. Kakkar, V., Mishra, A.K., Chuttani, K., Kaur, I.P., Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. Int. J. Pharm. 448 (2013), 354–359, 10.1016/j.ijpharm.2013.03.046.
169. Meng, F., Asghar, S., Xu, Y., Wang, J., Jin, X., Wang, Z., Wang, J., Ping, Q., Zhou, J., Xiao, Y., Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting. Int. J. Pharm. 506 (2016), 46–56, 10.1016/j.ijpharm.2016.04.033.
170. Montenegro, L., Campisi, A., Sarpietro, M.G., Carbone, C., Acquaviva, R., Raciti, G., Puglisi, G., In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev. Ind. Pharm. 37 (2011), 737–746, 10.3109/03639045.2010.539231.
171. Montenegro, L., Ottimo, S., Puglisi, G., Castelli, F., Sarpietro, M.G., Idebenone loaded solid lipid nanoparticles interact with biomembrane models: calorimetric evidence. Mol. Pharm. 9 (2012), 2534–2541, 10.1021/mp300149w.
172. Mandpe, L., Kyadarkunte, A., Pokharkar, V., Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential. Ther. Deliv. 4 (2013), 1365–1383, 10.4155/tde.13.101.
173. Leonardi, A., Crasci, L., Panico, A., Pignatello, R., Antioxidant activity of idebenone-loaded neutral and cationic solid–lipid nanoparticles. Pharm. Dev. Technol. 20 (2015), 716–723, 10.3109/10837450.2014.915572.
174. Priano, L., Zara, G.P., El-Assawy, N., Cattaldo, S., Muntoni, E., Milano, E., Serpe, L., Musicanti, C., Pérrot, C., Gasco, M.R., Miscio, G., Mauro, A., Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration. Eur. J. Pharm. Biopharm. 79 (2011), 135–141, 10.1016/j.ejpb.2011.02.009.
175. Patel, S., Chavhan, S., Soni, H., Babbar, A.K., Mathur, R., Mishra, A.K., Sawant, K., Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. J. Drug Target. 19 (2011), 468–474, 10.3109/1061186X.2010.523787.
176. Silva, A.C., Kumar, A., Wild, W., Ferreira, D., Santos, D., Forbes, B., Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Int. J. Pharm. 436 (2012), 798–805, 10.1016/j.ijpharm.2012.07.058.
177. Singh, S.K., Dadhania, P., Vuddanda, P.R., Jain, A., Velaga, S., Singh, S., Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment. RSC Adv. 6 (2016), 2032–2045, 10.1039/C5RA19793G.
178. Alam, M.I., Baboota, S., Ahuja, A., Ali, M., Ali, J., Sahni, J.K., Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J. Psychiatr. Res. 46 (2012), 1133–1138, 10.1016/j.jpsychires.2012.05.014.
179. Yang, Y., Yang, Y., Xie, X., Cai, X., Mei, X., Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. J. Drug Target. 22 (2014), 891–900, 10.3109/1061186X.2014.940589.
180. Almousallam, M., Moia, C., Zhu, H., Development of nanostructured lipid carrier for dacarbazine delivery. Int. Nano Lett. 5 (2015), 241–248, 10.1007/s40089-015-0161-8.